Investing Experts

Avoid IWM ETF due to Structural Issues

-2.79%current return

"I would never buy IWM."

Kirk expresses a strong negative view on IWM, citing that the Russell 2000 is largely populated by unprofitable companies and subject to volatility from retail manipulation. He advises investors to avoid this ETF in favor of more attractive opportunities.

Buy AMD on Bounce

+56.31%current return

"Another one that I just mentioned is AMD. We27re buy rated on AMD just because we think the stock has come down so much. I think it returned to the 160s, even high 150s level, which makes it attractive just for the bounce back."

Sara discusses a contrarian call on AMD, noting that the stock has moved into a lower price range and is positioned for a bounce back amid the current AI narrative. The call is based on its attractive valuation relative to market hype.

Comscope Holding Shows Strong All-Around Fundamentals

-3.66%current return

"Our second stock is Comscope Holding, ticker symbol COMM. ... Looking at the factor grades, green across the board with Bs and As, and it has a quant strong buy."

Comscope Holding (COMM) is presented as a strong pick from the quant system. The company displays solid factor grades across value, growth, profitability, momentum, and revisions. It benefits from strong industry tailwinds such as robust demand in data center infrastructure. The recommendation is derived from a blend of metrics that signal its competitive positioning, making it an actionable trade idea.

Vext Science (V-E-X-T-F) Offers High Growth and Value Edge

"Another U.S.-based one that's pretty interesting is Vext Science, ticker V-E-X-T-F. It operates in branded products and cultivation, has a market cap of around $60 million, gained 24% over the last month, with EBITDA margins 76% above the sector and forward EBITDA growth 677% above sector, alongside trailing discounts of about 70% in price-to-book and price-to-cash flow."

Vext Science, ticker V-E-X-T-F, is a high-potential, small-cap cannabis play. Its impressive recent momentum, substantial profitability advantages, and significant valuation discounts make it an actionable strong buy recommendation for investors looking to capitalize on the growth potential in the U.S. cannabis industry.

Verano Holdings (V-R-N-O-F) as a Quant Strong Buy

"One of those is Verano Holdings, ticker symbol V-R-N-O-F. It’s a decently large multi-state operator with a market cap around $500 million, trading at about an 80% discount in price-to-book relative to the sector, with CapEx growth at 98% versus a negative 6% sector median and a 25% EBITDA margin."

Verano Holdings, ticker V-R-N-O-F, presents an attractive buying opportunity given its strong quant metrics. With a market cap near $500M, significant valuation discounts, robust CapEx growth, and superior profitability metrics compared to its sector, it is positioned to benefit from potential legalization and regulatory tailwinds.

MSOS ETF Flipped to Buy Due to Regulatory Momentum

+8.77%current return

"So that is definitely one of the areas that's allowing MSOS to get into the buy category. It was a sell as recently as August 11th, but the news around potential descheduling of cannabis in the U.S. has propelled its momentum."

MSOS, the Advisor Shares Pure U.S. Cannabis ETF with approximately $840M in assets, has shifted its quant rating from sell to buy. Increased attention on regulatory changes, particularly potential descheduling, has boosted its momentum and liquidity, making it an actionable opportunity for investors seeking exposure to the U.S. cannabis market.

Buy BGH for High Short Duration Yield

-6.87%current return

"My latest buy from Friday was the Bering's Global Short Duration High Yield Bond Fund. And I started that off with a 1% position in that it's actually yielding 10% right now. There is a higher level of risk in bonds right now with we get into a rate cutting cycle."

David highlights initiating a position in BGH as a strategy to capture high yields in the short duration bond space amid an upcoming rate cutting cycle. With the fund yielding 10%, he is positioning to benefit from short-term bond income despite the leveraged risk inherent in the CEF structure.